Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism

Pär Ingemar Johansson, Jakob Stensballe, Sisse Rye Ostrowski, Pär Ingemar Johansson, Jakob Stensballe, Sisse Rye Ostrowski

Abstract

One quarter of patients suffering from acute critical illness such as severe trauma, sepsis, myocardial infarction (MI) or post cardiac arrest syndrome (PCAS) develop severe hemostatic aberrations and coagulopathy, which are associated with excess mortality. Despite the different types of injurious "hit", acutely critically ill patients share several phenotypic features that may be driven by the shock. This response, mounted by the body to various life-threatening conditions, is relatively homogenous and most likely evolutionarily adapted. We propose that shock-induced sympatho-adrenal hyperactivation is a critical driver of endothelial cell and glycocalyx damage (endotheliopathy) in acute critical illness, with the overall aim of ensuring organ perfusion through an injured microvasculature. We have investigated more than 3000 patients suffering from different types of acute critical illness (severe trauma, sepsis, MI and PCAS) and have found a potential unifying pathologic link between sympatho-adrenal hyperactivation, endotheliopathy, and poor outcome. We entitled this proposed disease entity, shock-induced endotheliopathy (SHINE). Here we review the literature and discuss the pathophysiology of SHINE.

Figures

Fig. 1
Fig. 1
Shock-induced endotheliopathy (SHINE). Schematic illustration of the changes in the vascular compartment with increasing disease severity and increasing sympatho-adrenal activation (Original figure)

References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442.
    1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127–30. doi: 10.1097/01.TA.0000069184.82147.06.
    1. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476–86. doi: 10.1097/SLA.0b013e3182658180.
    1. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65(4):748–54. doi: 10.1097/TA.0b013e3181877a9c.
    1. Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15(6):R272. doi: 10.1186/cc10553.
    1. Gando S, Sawamura A, Hayakawa M. Trauma, Shock and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. 2011;254(1):10–9. doi: 10.1097/SLA.0b013e31821221b1.
    1. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24–33. doi: 10.1111/j.1365-2141.2009.07600.x.
    1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–51. doi: 10.1056/NEJMra1208623.
    1. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Post resuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care. 2004;10(3):208–12. doi: 10.1097/01.ccx.0000126090.06275.fe.
    1. Kim J, Kim K, Lee JH, Jo YH, Kim T, Rhee JE, Kang KW. Prognostic implication of initial coagulopathy in out-of-hospital cardiac arrest. Resuscitation. 2013;84(1):48–53. doi: 10.1016/j.resuscitation.2012.09.003.
    1. Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: an update. Acta Anaesthesiol Scand. 2010;54(9):1039–49. doi: 10.1111/j.1399-6576.2010.02265.x.
    1. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses. 2010;75:564–7. doi: 10.1016/j.mehy.2010.07.031.
    1. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345(6):408–16. doi: 10.1056/NEJM200108093450603.
    1. Levi M, van der PT, Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol. 2012;34(1):167–79. doi: 10.1007/s00281-011-0283-7.
    1. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008;118(23):2452–83. doi: 10.1161/CIRCULATIONAHA.108.190652.
    1. Johansson PI, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, Cotton BA, Holcomb JB, Wade CE, Ostrowski SR. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg. 2016, in press.
    1. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2012;255(2):379–85. doi: 10.1097/SLA.0b013e318235d9e6.
    1. Aird WC. Endothelial cells in health and disease. Florida: Taylor & Francis Group; 2005.
    1. Hirase T, Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol. 2012;302(3):H499–505. doi: 10.1152/ajpheart.00325.2011.
    1. Broekhuizen LN, Mooij HL, Kastelein JJ, Stroes ES, Vink H, Nieuwdorp M. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr Opin Lipidol. 2009;20(1):57–62. doi: 10.1097/MOL.0b013e328321b587.
    1. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res. 2010;87(2):300–10. doi: 10.1093/cvr/cvq137.
    1. Levi M, van der Poll T. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin Thromb Hemost. 2008;34(5):459–68. doi: 10.1055/s-0028-1092876.
    1. Carroll RC, Craft RM, Langdon RJ, Clanton CR, Snider CC, Wellons DD, Dakin PA, Lawson CM, Enderson BL, Kurek SJ. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res. 2009;154(1):34–9. doi: 10.1016/j.trsl.2009.04.001.
    1. Cannon WB. Bodily changes in pain, hunger, fear and rage. An account of recent researches into the function of emotional excitement. 1. New York and London: D. Appleton and Co; 1915.
    1. Makhmudov RM, Mamedov Y, Dolgov VV, Repin VS. Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa. 1985;27(6):456–63.
    1. Dolgov VV, Makhmudov RM, Bondarenko MF, Repin VS. Deleterious action of adrenaline on the endothelial lining of the vessels. Arkh Patol. 1984;46(10):31–6.
    1. Opal SM, van der Poll T. Endothelial barrier dysfunction in septic shock. J Intern Med. 2015;277(3):277–93. doi: 10.1111/joim.12331.
    1. Holcomb JB. A novel and potentially unifying mechanism for shock induced early coagulopathy. Ann Surg. 2011;254(2):201–2. doi: 10.1097/SLA.0b013e318226483d.
    1. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581–614. doi: 10.1016/S1473-3099(15)70112-X.
    1. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation. 2002;106(5):562–8. doi: 10.1161/.
    1. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–90. doi: 10.1084/jem.20111354.
    1. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg. 2012;72(2):428–36. doi: 10.1097/TA.0b013e31821e0f93.
    1. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254(2):194–200. doi: 10.1097/SLA.0b013e318226113d.
    1. Ostrowski SR, Sorensen AM, Larsen CF, Johansson PI. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med. 2011;19(1):64. doi: 10.1186/1757-7241-19-64.
    1. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012;73(1):60–6. doi: 10.1097/TA.0b013e31825b5c10.
    1. Ostrowski SR, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, Cotton BA, Holcomb JB, Wade CE, Johansson PI: Sympathoadrenal activation and endotheliopathy are drivers of hypocoagulability and hyperfibrinolysis in trauma: A prospective observational study of 404 severely injured patients. J Trauma Acute Care Surg. 2016. In press.
    1. Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR. Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets and leukocytes in response to increasing injury severity. Crit Care Med. 2012;40(6):1844–50. doi: 10.1097/CCM.0b013e31823e9d15.
    1. Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care. 2013;17(1):R32. doi: 10.1186/cc12532.
    1. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma. 2005;58(3):475–80. doi: 10.1097/01.TA.0000153938.77777.26.
    1. Frohlich M, Lefering R, Probst C, Paffrath T, Schneider MM, Maegele M, Sakka SG, Bouillon B, Wafaisade A. Epidemiology and risk factors of multiple-organ failure after multiple trauma: an analysis of 31,154 patients from the TraumaRegister DGU. J Trauma Acute Care Surg. 2014;76(4):921–8. doi: 10.1097/TA.0000000000000199.
    1. Haywood-Watson R, Pati S, Kozar R, Faz J, Holcomb JB, Gonzalez E. Human micro-vascular barrier disruption after hemorrhagic shock. J Surg Res. 2010;158:313. doi: 10.1016/j.jss.2009.11.397.
    1. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One. 2011;6(8):e23530. doi: 10.1371/journal.pone.0023530.
    1. Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, Ostrowski SR, Johansson PI, Holcomb JB, Wade CE. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med. 2015;13:117. doi: 10.1186/s12967-015-0481-5.
    1. Di Battista AP, Rizoli SB, Lejnieks B, Min A, Shiu MY, Peng HT, Baker AJ, Hutchison MG, Churchill N, Inaba K, et al. Sympathoadrenal activation is associated with acute traumatic coagulopathy and endotheliopathy in isolated brain injury. Shock. 2016;46:96–103. doi: 10.1097/SHK.0000000000000642.
    1. Ostrowski SR, Haase N, Müller RB, Moller MH, Pott FC, Perner A, Johansson PI. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis. A prospective study. Crit Care. 2015;19(1):191–200. doi: 10.1186/s13054-015-0918-5.
    1. Johansson PI, Haase N, Perner A, Ostrowski SR. Association between sympathoadrenal activation, fibrinolysis and endothelial damage in septic patients: a prospective study. J Crit Care. 2014;29(3):327–33. doi: 10.1016/j.jcrc.2013.10.028.
    1. Johansen ME, Johansson PI, Ostrowski SR, Bestle MH, Hein L, Jensen ALG, Soe-Jensen P, Andersen MH, Steensen M, Mohr T, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost. 2015;41(1):16–25. doi: 10.1055/s-0034-1398377.
    1. Hayashida K, Chen Y, Bartlett AH, Park PW. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J Biol Chem. 2008;283(29):19895–903. doi: 10.1074/jbc.M801614200.
    1. Steppan J, Hofer S, Funke B, Brenner T, Henrich M, Martin E, Weitz J, Hofmann U, Weigand MA. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165(1):136–41. doi: 10.1016/j.jss.2009.04.034.
    1. Connolly-Andersen AM, Thunberg T, Ahlm C. Endothelial activation and repair during hantavirus infection: association with disease outcome. Open Forum Infect Dis. 2014;1(1):ofu027. doi: 10.1093/ofid/ofu027.
    1. Schmidt EP, Overdier KH, Sun X, Lin L, Liu X, Yang Y, Ammons LA, Hiller TD, Suflita MA, Yu Y, et al. Urinary glycosaminoglycans predict outcomes in septic shock and ARDS. Am J Respir Crit Care Med. 2016;194:439–49. doi: 10.1164/rccm.201511-2281OC.
    1. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896–906. doi: 10.1161/CIRCULATIONAHA.106.684852.
    1. Bruegger D, Rehm M, Abicht J, Paul JO, Stoeckelhuber M, Pfirrmann M, Reichart B, Becker BF, Christ F. Shedding of the endothelial glycocalyx during cardiac surgery: on-pump versus off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2009;138(6):1445–7. doi: 10.1016/j.jtcvs.2008.07.063.
    1. Schochl H, Cadamuro J, Seidl S, Franz A, Solomon C, Schlimp CJ, Ziegler B. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: results from a prospective observational thromboelastometry study. Resuscitation. 2013;84(4):454–9. doi: 10.1016/j.resuscitation.2012.08.318.
    1. Grundmann S, Fink K, Rabadzhieva L, Bourgeois N, Schwab T, Moser M, Bode C, Busch HJ. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation. 2012;83(6):715–20. doi: 10.1016/j.resuscitation.2012.01.028.
    1. Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206. doi: 10.1056/NEJMoa1310519.
    1. Johansson PI, Bro-Jeppesen J, Kjaergaard J, Wanscher M, Hassager C, Ostrowski SR. Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest: a post hoc sub-study of patients from the TTM-trial. PLoS One. 2015;10(3):e0120914. doi: 10.1371/journal.pone.0120914.
    1. Jung C, Fuernau G, Muench P, Desch S, Eitel I, Schuler G, Adams V, Figulla HR, Thiele H. Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance. Shock. 2015;43(5):450–5. doi: 10.1097/SHK.0000000000000329.
    1. Xu L, Yu WK, Lin ZL, Tan SJ, Bai XW, Ding K, Li N. Chemical sympathectomy attenuates inflammation, glycocalyx shedding and coagulation disorders in rats with acute traumatic coagulopathy. Blood Coagul Fibrinolysis. 2015;26:152–60. doi: 10.1097/MBC.0000000000000211.
    1. Opal SM, Dellinger RP, Vincent JL, Masur H, Angus DC. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med. 2014;42(7):1714–21. doi: 10.1097/CCM.0000000000000325.
    1. Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA. 2011;306(23):2614–5. doi: 10.1001/jama.2011.1853.
    1. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63. doi: 10.1056/NEJMoa003289.
    1. The Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56. doi: 10.1056/NEJMoa012689.
    1. Villablanca PA, Makkiya M, Einsenberg E, Briceno DF, Panagiota C, Menegus M, Garcia M, Sims D, Ramakrishna H. Mild therapeutic hypothermia in patients resuscitated from out-of-hospital cardiac arrest: a meta-analysis of randomized controlled trials. Ann Card Anaesth. 2016;19(1):4–14. doi: 10.4103/0971-9784.173013.
    1. Johansson PI, Sørensen AM, Larsen CF, Windeløv NA, Stensballe J, Perner A, Rasmussen LS, Ostrowski SR. Low hemorrhage-related mortality in trauma patients in a Level I Trauma Centre employing transfusion packages and early thrombelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion. 2013;53(12):3088–99. doi: 10.1111/trf.12214.
    1. Johansson PI, Oliveri R, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. A meta-analysis. J Emerg Trauma Shock. 2012;5(2):120–5. doi: 10.4103/0974-2700.96479.
    1. Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood. 2014;124(20):352–8. doi: 10.1182/blood-2014-05-575340.
    1. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82. doi: 10.1001/jama.2015.12.
    1. Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2015;263(6):1051–9. doi: 10.1097/SLA.0000000000001608.
    1. Norris RM, Clarke ED, Sammel NL, Smith WM, Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978;2(8096):907–9. doi: 10.1016/S0140-6736(78)91628-8.
    1. Chatterjee S, Chaudhuri D, Vedanthan R, Fuster V, Ibanez B, Bangalore S, Mukherjee D. Early intravenous beta-blockers in patients with acute coronary syndrome–a meta-analysis of randomized trials. Int J Cardiol. 2013;168(2):915–21. doi: 10.1016/j.ijcard.2012.10.050.
    1. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D’Egidio A, D’Ippoliti F, Raffone C, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683–91. doi: 10.1001/jama.2013.278477.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa